Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Milnacipran for Idiopathic Neuropathy Pain
NCT01288937Phase 3Terminated
- Sponsor
- Columbia University
- Start
- Apr 2011
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of milnacipran in idiopathic peripheral neuropathy, sponsored by Columbia University. Started Apr 2011; status: terminated.
02
Drugs
milnacipran
03
Conditions
idiopathic peripheral neuropathy
Beyond the preview
Go deeper on NCT01288937.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01288937.